Use of Aztreonam-avibactam for infections caused by MBL-producing Enterobacterales
Filippo Medioli(University of Siena), Michele Bartoletti(Humanitas University), Cristina Scuderi(IRCCS Humanitas Research Hospital), Carmelo Carlo-Stella(Humanitas University), Davide Fiore Bavaro(Humanitas University), Alessandro Cilli(IRCCS Humanitas Research Hospital), Lucia Diella(Humanitas University), Federica Tordato(Humanitas University), Stéfania Bramanti(Istituti di Ricovero e Cura a Carattere Scientifico), Paola Morelli(Humanitas University), Maddalena Casana(IRCCS Humanitas Research Hospital), Linda Bussini(University of Bologna), Matteo Giovanni Della Porta(Humanitas University), Massimo Vanoni(IRCCS Humanitas Research Hospital), Maurizio Cecconi(Humanitas University), Elena Costantini(IRCCS Humanitas Research Hospital), Benedetta Varisco(Humanitas University), Valeria Cento(Rostov State Medical University)
Cited by 0
Related Papers
Clinical and biological implications of driver mutations in myelodysplastic syndromes
|Blood|2013|1.8k
Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts
|New England Journal of Medicine|2011|1.2k
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
|Nature Medicine|2020|633
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
|The Lancet Haematology|2020|553
Hospital-Acquired Infections in Critically Ill Patients With COVID-19
|CHEST Journal|2021|404